Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
23.47
+1.31 (5.91%)
At close: Mar 10, 2026, 4:00 PM EDT
23.13
-0.34 (-1.45%)
Pre-market: Mar 11, 2026, 4:57 AM EDT
Hims & Hers Health Revenue
In the year 2025, Hims & Hers Health had annual revenue of $2.35B with 59.00% growth. Hims & Hers Health had revenue of $617.82M in the quarter ending December 31, 2025, with 28.41% growth.
Revenue (ttm)
$2.35B
Revenue Growth
+59.00%
P/S Ratio
2.28
Revenue / Employee
$961,358
Employees
2,442
Market Cap
5.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.35B | 871.12M | 59.00% |
| Dec 31, 2024 | 1.48B | 604.51M | 69.33% |
| Dec 31, 2023 | 872.00M | 345.08M | 65.49% |
| Dec 31, 2022 | 526.92M | 255.04M | 93.81% |
| Dec 31, 2021 | 271.88M | 123.12M | 82.77% |
| Dec 31, 2020 | 148.76M | 66.20M | 80.18% |
| Dec 31, 2019 | 82.56M | 55.88M | 209.45% |
| Dec 31, 2018 | 26.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elanco Animal Health | 4.72B |
| Dr. Reddy's Laboratories | 3.85B |
| Amneal Pharmaceuticals | 3.02B |
| Lantheus Holdings | 1.54B |
| Alkermes | 1.48B |
| Prestige Consumer Healthcare | 1.10B |
| BioCryst Pharmaceuticals | 874.84M |
| Supernus Pharmaceuticals | 718.95M |
HIMS News
- 8 hours ago - Hims & Hers Names Kathryn Beiser as Chief Communications Officer - Business Wire
- 12 hours ago - Hims & Hers Health: The GLP-1 Chaos Is Fading, The Thesis Is Still On Track - Seeking Alpha
- 20 hours ago - Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers - Business Wire
- 1 day ago - Hims & Hers: Not Selling Yet - Seeking Alpha
- 1 day ago - Hims & Hers Health: The Juice Is Worth The Squeeze - Seeking Alpha
- 1 day ago - Stock Of The Day: Will Hims & Hers Go Into Another Short Squeeze? - Benzinga
- 1 day ago - Hims & Hers stock: why today's gains are unlikely to be sustainable - Invezz
- 1 day ago - Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS - Business Wire